These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12756203)

  • 1. Distinct tissue distribution of metabolites of the novel glutathione-activated thiopurine prodrugs cis-6-(2-acetylvinylthio)purine and trans-6-(2-acetylvinylthio)guanine and 6-thioguanine in the mouse.
    Gunnarsdottir S; Elfarra AA
    Drug Metab Dispos; 2003 Jun; 31(6):718-26. PubMed ID: 12756203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glutathione-activated thiopurine prodrugs trans-6-(2-acetylvinylthio)guanine and cis-6-(2-acetylvinylthio)purine cause less in vivo toxicity than 6-thioguanine after single- and multiple-dose regimens.
    Gunnarsdottir S; Rucki M; Phillips LA; Young KM; Elfarra AA
    Mol Cancer Ther; 2002 Nov; 1(13):1211-20. PubMed ID: 12479702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of the novel glutathione-activated thiopurine prodrugs cis-AVTP [cis-6-(2-acetylvinylthio)purine] and trans-AVTG [trans-6-(2-acetylvinylthio)guanine] results from the National Cancer Institute's anticancer drug screen.
    Gunnarsdottir S; Elfarra AA
    Drug Metab Dispos; 2004 Mar; 32(3):321-7. PubMed ID: 14977866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel glutathione-dependent thiopurine prodrugs: evidence for enhanced cytotoxicity in tumor cells and for decreased bone marrow toxicity in mice.
    Gunnarsdottir S; Rucki M; Elfarra AA
    J Pharmacol Exp Ther; 2002 Apr; 301(1):77-86. PubMed ID: 11907160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting 6-thioguanine to the kidney with S-(guanin-6-yl)-L-cysteine.
    Elfarra AA; Duescher RJ; Hwang IY; Sicuri AR; Nelson JA
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1298-304. PubMed ID: 7562502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations and organ distribution of thiopurines after oral application of azathioprine in mice.
    Kurowski V; Iven H
    Cancer Chemother Pharmacol; 1991; 28(1):7-14. PubMed ID: 2040036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human glutathione transferases catalyzing the bioactivation of anticancer thiopurine prodrugs.
    Eklund BI; Gunnarsdottir S; Elfarra AA; Mannervik B
    Biochem Pharmacol; 2007 Jun; 73(11):1829-41. PubMed ID: 17433263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione-dependent metabolism of cis-3-(9H-purin-6-ylthio)acrylic acid to yield the chemotherapeutic drug 6-mercaptopurine: evidence for two distinct mechanisms in rats.
    Gunnarsdottir S; Elfarra AA
    J Pharmacol Exp Ther; 1999 Sep; 290(3):950-7. PubMed ID: 10454464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leucocyte versus erythrocyte thioguanine nucleotide concentrations in children taking thiopurines for acute lymphoblastic leukaemia.
    Lancaster DL; Patel N; Lennard L; Lilleyman JS
    Cancer Chemother Pharmacol; 2002 Jul; 50(1):33-6. PubMed ID: 12111109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of 6-thioguanine and 6-mercaptopurine from their 9-alkyl derivatives in mice.
    Nelson JA; Vidale E
    Cancer Res; 1986 Jan; 46(1):137-40. PubMed ID: 3940185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells.
    Dervieux T; Blanco JG; Krynetski EY; Vanin EF; Roussel MF; Relling MV
    Cancer Res; 2001 Aug; 61(15):5810-6. PubMed ID: 11479220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of a hypervariable active-site residue in human Mu class glutathione transferases catalyzing the bioactivation of chemotherapeutic thiopurine prodrugs.
    Eklund BI; Mannervik B
    Biochim Biophys Acta; 2007 Aug; 1770(8):1098-103. PubMed ID: 17493759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended thiopurine metabolite assessment during 6-thioguanine therapy for immunomodulation in Crohn's disease.
    de Boer NK; Derijks LJ; Keizer-Garritsen JJ; Lambooy LH; Ruitenbeek W; Hooymans PM; van Bodegraven AA; de Jong DJ
    J Clin Pharmacol; 2007 Feb; 47(2):187-91. PubMed ID: 17244769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport and metabolism of 6-thioguanine and 6-mercaptopurine in mouse small intestine.
    Bronk JR; Lister N; Shaw MI
    Clin Sci (Lond); 1988 Jun; 74(6):629-38. PubMed ID: 3396300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of Concentrations of Azathioprine Metabolites 6-Thioguanine and 6-Methylmercaptopurine in Whole Blood With the Use of Liquid Chromatography Combined With Mass Spectrometry.
    Zochowska D; Zegarska J; Hryniewiecka E; Samborowska E; Jazwiec R; Tszyrsznic W; Borowiec A; Dadlez M; Paczek L
    Transplant Proc; 2016 Jun; 48(5):1836-9. PubMed ID: 27496503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase.
    Krynetski EY; Krynetskaia NF; Yanishevski Y; Evans WE
    Mol Pharmacol; 1995 Jun; 47(6):1141-7. PubMed ID: 7603453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azathioprine metabolism: pharmacokinetics of 6-mercaptopurine, 6-thiouric acid and 6-thioguanine nucleotides in renal transplant patients.
    Chan GL; Erdmann GR; Gruber SA; Matas AJ; Canafax DM
    J Clin Pharmacol; 1990 Apr; 30(4):358-63. PubMed ID: 2341582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential role of thiopurine methyltransferase in the cytotoxic effects of 6-mercaptopurine and 6-thioguanine on human leukemia cells.
    Karim H; Ghalali A; Lafolie P; Vitols S; Fotoohi AK
    Biochem Biophys Res Commun; 2013 Jul; 437(2):280-6. PubMed ID: 23811272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma pharmacokinetics and cerebrospinal fluid penetration of thioguanine in children with acute lymphoblastic leukemia: a collaborative Pediatric Oncology Branch, NCI, and Children's Cancer Group study.
    Lowe ES; Kitchen BJ; Erdmann G; Stork LC; Bostrom BC; Hutchinson R; Holcenberg J; Reaman GH; Woods W; Franklin J; Widemann BC; Balis FM; Murphy RF; Adamson PC
    Cancer Chemother Pharmacol; 2001 Mar; 47(3):199-205. PubMed ID: 11320662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus.
    Relling MV; Hancock ML; Rivera GK; Sandlund JT; Ribeiro RC; Krynetski EY; Pui CH; Evans WE
    J Natl Cancer Inst; 1999 Dec; 91(23):2001-8. PubMed ID: 10580024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.